PT-141 10mg

Chemical Information:

• Molecular Formula: C₅₀H₆₈N₁₄O₁₀
• Molecular Weight: 1025.16 g/mol
• Sequence: Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH
• Molecular Structure: Refer to Certificate of Analysis for detailed structural information.

Description:
PT-141, also known as Bremelanotide, is a synthetic cyclic peptide analog of the alpha-melanocyte-stimulating hormone (α-MSH). Extensively studied for its role in modulating melanocortin receptors, PT-141 research primarily focuses on pathways related to sexual function, arousal, and potential neurological impacts. Provided as a lyophilized powder, PT-141 supports advanced laboratory research examining melanocortin receptor signaling and physiological responses.

Research Applications:
PT-141 is actively studied for potential roles in:

• Sexual Function and Arousal: Investigating its mechanism of action in enhancing sexual desire and arousal through melanocortin receptor activation.
• Neurological Pathways: Exploring central nervous system interactions related to sexual function modulation and behavior in research models.
• Energy Homeostasis Studies: Examining melanocortin receptor-mediated effects on energy regulation and metabolic signaling pathways.
• Melanocortin Receptor Activity: Assessing its selective agonist effects on MC-3 and MC-4 receptors and related physiological processes.

Storage and Handling:

• Store lyophilized powder at -20°C.
• After reconstitution, refrigerate at 2-8°C and use promptly.
• Maintain aseptic handling practices to ensure sterility and product integrity.

Product Specifications:

• Purity: ≥99% (HPLC Verified)
• Appearance: Lyophilized white powder
• Solubility: Soluble in bacteriostatic water

Important Note:
This product is strictly FOR RESEARCH USE ONLY and is intended exclusively for in vitro research and laboratory experimentation by qualified professionals. It is not a drug, food, cosmetic, or dietary supplement, and has not been evaluated by the FDA. This peptide is not intended to diagnose, treat, cure, or prevent any disease. The bodily introduction into humans or animals is strictly prohibited by law. Any misuse, misbranding, or mislabeling is a violation of federal regulations and may result in legal action under applicable federal, state, or local laws.

References:
Referenced scientific publications include:

• Molinoff, P. B., et al. (2003). “PT-141: A Melanocortin Agonist for the Treatment of Sexual Dysfunction.” Annals of the New York Academy of Sciences.
• Clayton, A. H., et al. (2016). “Bremelanotide for Female Sexual Dysfunction Disorders.” Expert Opinion on Investigational Drugs.